Skip to main content
Signal8

cbdMD, Inc. Form SCHEDULE 13D — Nov 4, 2026

Form SCHEDULE 13DFiled Nov 4, 2026, 7:16 PM ET0001437749-26-035032Original filing

Akretive Holdings, LLC filed a Schedule 13D disclosing beneficial ownership of 2,229,805 shares of cbdMD, Inc. common stock, approximately 15.9% of the 14,048,386 shares outstanding as of October 30, 2026. The stake was acquired on October 30, 2026 under an Asset Purchase Agreement dated September 1, 2026 among cbdMD, To Be Brands, Twinlab Consolidated Holdings, and a court-appointed assignee for the benefit of creditors; Akretive also received a Senior Secured Promissory Note.

Key figures

Shares Outstanding
14048386
Shares owned
2229805
Percent owned
15.9%
Acquisition date
2026-10-30
Asset purchase agreement date
2026-09-01

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    cbdMD, Inc. Form SCHEDULE 13D — Nov 4, 2026: AI Analysis | Signal8